Journal article icon

Journal article

Beta-Agonist Lung injury TrIal-2 (BALTI-2): a multicentre, randomised, double-blind, placebo-controlled trial and economic evaluation of intravenous infusion of salbutamol versus placebo in patients with acute respiratory distress syndrome.

Abstract:

Acute respiratory distress syndrome (ARDS) is a major cause of mortality in intensive care patients and lacks effective treatments. A previous randomised controlled Phase II trial suggested that an intravenous (i.v.) infusion of salbutamol may be beneficial, as it reduced extravascular lung water and plateau airway pressure. The Beta-Agonist Lung injury TrIal-2 (BALTI-2) was initiated to evaluate the effects of this intervention on mortality in patients with ARDS. To evaluate whether or not, ...

Expand abstract

Actions


Authors


Perkins, GD More by this author
More by this author
Institution:
University of Oxford
Department:
Oxford, MSD, NDORMS
Thickett, DR More by this author
Expand authors...
Journal:
Health technology assessment (Winchester, England)
Volume:
17
Issue:
38
Publication date:
2013-09-05
EISSN:
2046-4924
URN:
uuid:b17a8a4d-fab8-4411-84a7-80614d84ab29
Source identifiers:
465515
Local pid:
pubs:465515

Terms of use


Metrics



If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP